- Home
- IMRX vs PRHIZ Comparison
IMRX vs PRHIZ Comparison
Compare IMRX & PRHIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRX
- PRHIZ
- Stock Information
- Founded
- IMRX 2008
- PRHIZ N/A
- Country
- IMRX United States
- PRHIZ United States
- Employees
- IMRX N/A
- PRHIZ N/A
- Industry
- IMRX Biotechnology: Pharmaceutical Preparations
- PRHIZ Property-Casualty Insurers
- Sector
- IMRX Health Care
- PRHIZ Finance
- Exchange
- IMRX Nasdaq
- PRHIZ Nasdaq
- Market Cap
- IMRX 232.9M
- PRHIZ 220.0M
- IPO Year
- IMRX 2021
- PRHIZ N/A
- Fundamental
- Price
- IMRX $6.49
- PRHIZ $20.40
- Analyst Decision
- IMRX Strong Buy
- PRHIZ
- Analyst Count
- IMRX 4
- PRHIZ 0
- Target Price
- IMRX $17.75
- PRHIZ N/A
- AVG Volume (30 Days)
- IMRX 1.9M
- PRHIZ N/A
- Earning Date
- IMRX 11-12-2025
- PRHIZ N/A
- Dividend Yield
- IMRX N/A
- PRHIZ N/A
- EPS Growth
- IMRX N/A
- PRHIZ N/A
- EPS
- IMRX N/A
- PRHIZ N/A
- Revenue
- IMRX N/A
- PRHIZ N/A
- Revenue This Year
- IMRX N/A
- PRHIZ N/A
- Revenue Next Year
- IMRX N/A
- PRHIZ N/A
- P/E Ratio
- IMRX N/A
- PRHIZ N/A
- Revenue Growth
- IMRX N/A
- PRHIZ N/A
- 52 Week Low
- IMRX $1.10
- PRHIZ N/A
- 52 Week High
- IMRX $10.08
- PRHIZ N/A
- Technical
- Relative Strength Index (RSI)
- IMRX 51.11
- PRHIZ N/A
- Support Level
- IMRX $5.23
- PRHIZ N/A
- Resistance Level
- IMRX $6.44
- PRHIZ N/A
- Average True Range (ATR)
- IMRX 0.44
- PRHIZ 0.00
- MACD
- IMRX -0.00
- PRHIZ 0.00
- Stochastic Oscillator
- IMRX 71.58
- PRHIZ 0.00
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.